Showing results (11-20 of 130) with videos related to
Sort By:
Pageof 13
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 24, 2023
Prognosis in stage II melanoma of the head and neck depends on the histological subtypeSophie Jasper, Ulrike Keim, Ulrike Leiter, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNALukas Flatz, Andreas Bergthaler, Juan Carlos de la Torre, et al.International Journal of Cancer|July 20, 2024
Response and outcome of patients with melanoma skin metastases and immune checkpoint inhibitionAndrea Forschner, Lena Nanz, Yves Maczey-Leber, et al.Dermatology (Basel, Switzerland)|November 7, 2013
Anti-TNF therapy in the treatment of psoriasis in a patient with acute-on-chronic pancreatitisHelena Clayton, Lukas Flatz, Sonia Vollenweider-Roten, et al.Oncology Research and Treatment|May 8, 2018
Anti-PD-1 Therapy Leads to Near-Complete Remission in a Patient with Metastatic Basal Cell CarcinomaStefanie Fischer, Omar Hasan Ali, Wolfram Jochum, et al.BMC Cancer|August 21, 2016
Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesotheliomaAngelika Bickel, Irene Koneth, Annette Enzler-Tschudy, et al.Journal of Cancer Research and Clinical Oncology|January 18, 2024
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017Markus Reitmajer, Ulrike Leiter, Lena Nanz, et al.Cancers|January 21, 2022
Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic MelanomaMarcus Wölffer, Florian Battke, Martin Schulze, et al.Ocular Immunology and Inflammation|August 5, 2020
Ocular Adverse Events Induced by Immune Checkpoint Inhibitors: A Comprehensive Pharmacovigilance AnalysisDavid Bomze, Tomer Meirson, Omar Hasan Ali, et al.JAMA Network Open|October 23, 2020
Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint InhibitorsDavid Bomze, Nethanel Asher, Omar Hasan Ali, et al.Pageof 13